Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41572-020-0205-x
10.1038/s41572-020-0205-x · External reference
10.1038/s41586-020-2025-2
10.1038/s41586-020-2025-2 · External reference
Ulcerative colitis: towards remission
10.1038/d41586-018-07276-2 · 2018 · External reference
10.1056/nejmra2002697
10.1056/nejmra2002697 · External reference
10.1016/j.immuni.2018.12.028
10.1016/j.immuni.2018.12.028 · External reference
Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease
2016 · External reference
10.1016/j.immuni.2018.12.015
10.1016/j.immuni.2018.12.015 · External reference
10.1038/s41586-019-1237-9
10.1038/s41586-019-1237-9 · External reference
10.1038/s41598-017-10034-5
10.1038/s41598-017-10034-5 · External reference
10.1038/s41564-018-0306-4
10.1038/s41564-018-0306-4 · External reference
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals
10.1007/s11306-014-0677-3 · 2015 · External reference
A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations
10.1186/s40168-021-01149-z · 2021 · External reference
Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor
2020 · External reference
10.1007/s00535-016-1242-9
10.1007/s00535-016-1242-9 · External reference
10.1186/s40168-019-0689-3
10.1186/s40168-019-0689-3 · External reference
10.1093/ibd/izaa262
10.1093/ibd/izaa262 · External reference
10.1016/j.tim.2016.06.008
10.1016/j.tim.2016.06.008 · External reference
A perspective on 16S rRNA operational taxonomic unit clustering using sequence similarity
10.1038/npjbiofilms.2016.4 · 2016 · External reference
10.1038/nature08821
10.1038/nature08821 · External reference
10.1126/science.1237439
10.1126/science.1237439 · External reference
10.1186/gb-2011-12-5-r50
10.1186/gb-2011-12-5-r50 · External reference
10.1016/j.chom.2018.09.009
10.1016/j.chom.2018.09.009 · External reference
10.1053/j.gastro.2011.04.011
10.1053/j.gastro.2011.04.011 · External reference
10.1016/j.chom.2014.02.005
10.1016/j.chom.2014.02.005 · External reference
Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis
10.1002/mbo3.1181 · 2021 · External reference
10.1093/ibd/izaa188
10.1093/ibd/izaa188 · External reference
10.1093/ecco-jcc/jjv209
10.1093/ecco-jcc/jjv209 · External reference
10.1038/nbt.3935
10.1038/nbt.3935 · External reference
10.1146/annurev-micro-012520-072314
10.1146/annurev-micro-012520-072314 · External reference
Multi-“-Omics” profiling in patients with quiescent inflammatory bowel disease identifies biomarkers predicting relapse
10.1093/ibd/izaa183 · 2020 · External reference
10.1053/j.gastro.2019.11.294
10.1053/j.gastro.2019.11.294 · External reference
10.1038/nrgastro.2012.14
10.1038/nrgastro.2012.14 · External reference
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae
10.1016/j.chom.2007.08.002 · 2007 · External reference
The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
10.3390/microorganisms9040697 · 2021 · External reference
10.1053/j.gastro.2020.09.036
10.1053/j.gastro.2020.09.036 · External reference
10.1126/science.aan4526
10.1126/science.aan4526 · External reference
10.1002/ibd.21606
10.1002/ibd.21606 · External reference
10.1016/j.cell.2017.01.022
10.1016/j.cell.2017.01.022 · External reference
10.1016/s0140-6736(17)30182-4
10.1016/s0140-6736(17)30182-4 · External reference
Faecalibacterium prausnitzii Attenuates DSS-Induced Colitis by Inhibiting the Colonization and Pathogenicity of Candida albicans
10.1002/mnfr.202100433 · 2021 · External reference
10.1136/gutjnl-2016-312135
10.1136/gutjnl-2016-312135 · External reference
Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response
2019 · External reference
Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis
2018 · External reference
Roseburia intestinalis-derived flagellin is a negative regulator of intestinal inflammation
10.1016/j.bbrc.2018.05.075 · 2018 · External reference
Reduced metagenome sequencing for strain-resolution taxonomic profiles
10.1186/s40168-021-01019-8 · 2021 · External reference
10.1038/s41587-019-0183-2
10.1038/s41587-019-0183-2 · External reference
10.1038/s41586-020-2983-4
10.1038/s41586-020-2983-4 · External reference
Amount and fate of egg protein escaping assimilation in the small intestine of humans
1999 · External reference
10.1038/4551054a
10.1038/4551054a · External reference
HMDB 3.0–The Human Metabolome Database in 2013
10.1093/nar/gks1065 · 2013 · External reference
10.1007/978-1-4939-7172-5_13
10.1007/978-1-4939-7172-5_13 · 2017 · External reference
10.1039/c1an15605e
10.1039/c1an15605e · External reference
10.1053/j.gastro.2014.03.001
10.1053/j.gastro.2014.03.001 · External reference
Dietary lipids, gut microbiota and lipid metabolism
10.1007/s11154-019-09512-0 · 2019 · External reference
10.1177/0148607115595980
10.1177/0148607115595980 · External reference
Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper
10.1159/000228994 · 2009 · External reference
10.1016/j.cell.2016.05.041
10.1016/j.cell.2016.05.041 · External reference
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease
10.1021/pr060470d · 2007 · External reference
10.1136/gutjnl-2013-304833
10.1136/gutjnl-2013-304833 · External reference
10.1038/s41467-020-18262-6
10.1038/s41467-020-18262-6 · External reference
IL-33 Is Involved in the Anti-Inflammatory Effects of Butyrate and Propionate on TNFα-Activated Endothelial Cells
2021 · External reference
10.1038/s41586-021-03727-5
10.1038/s41586-021-03727-5 · External reference
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
10.3389/fimmu.2019.00277 · 2019 · External reference
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases
10.1080/19490976.2021.1882927 · 2021 · External reference
Effects of intraluminal infusion of short-chain fatty acids on the healing of colonic anastomosis in the rat
1986 · External reference
Serological Biomarkers and Diversion Colitis: Changes after Stimulation with Probiotics
10.3390/biom11050684 · 2021 · External reference
Treatment of diversion colitis with short-chain fatty acids. Bacteriological study
1995 · External reference
Relationship between the severity of diversion colitis and the composition of colonic bacteria: a prospective study
10.5009/gnl.2014.8.2.170 · 2014 · External reference
Diversion colitis and pouchitis: A mini-review
10.3748/wjg.v24.i16.1734 · 2018 · External reference
Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
2021 · External reference
Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: A randomized trial
10.1016/j.dld.2015.09.005 · 2016 · External reference
Diversion proctocolitis and response to treatment with short-chain fatty acids–a clinicopathological study in children
10.1007/s12664-015-0577-0 · 2015 · External reference
10.1136/gutjnl-2013-306423
10.1136/gutjnl-2013-306423 · External reference
The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study
2020 · External reference
The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease
2019 · External reference
10.1016/j.mce.2021.111448
10.1016/j.mce.2021.111448 · External reference
N-3 polyunsaturated fatty acid-enriched lipid emulsion improves Paneth cell function via the IL-22/Stat3 pathway in a mouse model of total parenteral nutrition
10.1016/j.bbrc.2017.06.032 · 2017 · External reference
10.1136/gutjnl-2020-321173
10.1136/gutjnl-2020-321173 · External reference
Long-chain monounsaturated fatty acids improve endothelial function with altering microbial flora
10.1016/j.trsl.2021.03.016 · 2021 · External reference
10.1096/fj.06-6927com
10.1096/fj.06-6927com · External reference
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis
10.1371/journal.pone.0031238 · 2012 · External reference
Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid
10.1016/j.jdermsci.2013.10.010 · 2014 · External reference
Lauric acid ameliorates lipopolysaccharide (LPS)-induced liver inflammation by mediating TLR4/MyD88 pathway in Sprague Dawley (SD) rats
2021 · External reference
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease, Nature Reviews
2020 · External reference
10.1038/s41467-018-05470-4
10.1038/s41467-018-05470-4 · External reference
10.1038/s41575-021-00430-8
10.1038/s41575-021-00430-8 · External reference
10.1053/j.gastro.2017.08.028
10.1053/j.gastro.2017.08.028 · External reference
10.1038/nm.4102
10.1038/nm.4102 · External reference
Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells
10.1126/science.aah5825 · 2017 · External reference
Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner
10.1172/jci.insight.127551 · 2020 · External reference
10.1016/j.immuni.2013.08.003
10.1016/j.immuni.2013.08.003 · External reference
10.1146/annurev.pharmtox.41.1.79
10.1146/annurev.pharmtox.41.1.79 · External reference
10.1097/mib.0000000000000790
10.1097/mib.0000000000000790 · External reference
Alterations in lipid, amino acid, and energy metabolism distinguish crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling
10.1007/s11306-017-1311-y · 2018 · External reference
Transcriptional and metabolomic analysis of l-arginine/nitric oxide pathway in inflammatory bowel disease and its association with local inflammatory and angiogenic response: preliminary findings
10.3390/ijms21051641 · 2020 · External reference
10.1016/j.tips.2015.03.006
10.1016/j.tips.2015.03.006 · External reference
Arginase impedes the resolution of colitis by altering the microbiome and metabolome
10.1172/jci126923 · 2020 · External reference
Pretreatment and Treatment With L-Arginine Attenuate Weight Loss and Bacterial Translocation in Dextran Sulfate Sodium Colitis
10.1177/0148607115581374 · 2016 · External reference
10.1146/annurev-nutr-120419-015419
10.1146/annurev-nutr-120419-015419 · External reference
10.1111/j.1348-0421.2007.tb03887.x
10.1111/j.1348-0421.2007.tb03887.x · External reference
Polyamines and Gut Microbiota
10.3389/fnut.2019.00016 · 2019 · External reference
Preventive and therapeutic spermidine treatment attenuates acute colitis in mice
10.1021/acs.jafc.0c07095 · 2021 · External reference
Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice
2020 · External reference
10.1152/ajpgi.2001.280.5.g992
10.1152/ajpgi.2001.280.5.g992 · External reference
10.1080/713609209
10.1080/713609209 · External reference
10.1016/j.jaci.2020.04.037
10.1016/j.jaci.2020.04.037 · External reference
10.1038/s41467-021-22212-1
10.1038/s41467-021-22212-1 · External reference
10.1053/j.gastro.2020.07.003
10.1053/j.gastro.2020.07.003 · External reference
Faecal and serum metabolomics in paediatric inflammatory bowel disease
2017 · External reference
10.1016/j.chom.2020.07.020
10.1016/j.chom.2020.07.020 · External reference
Untargeted metabolomics of extracts from faecal samples demonstrates distinct differences between paediatric crohn's disease patients and healthy controls but no significant changes resulting from exclusive enteral nutrition treatment
10.3390/metabo8040082 · 2018 · External reference
Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease
10.1038/s41598-020-75306-z · 2020 · External reference
A 12-month pilot study outcomes of vagus nerve stimulation in Crohn's disease
10.1111/nmo.13911 · 2020 · External reference
Taurine can ameliorate inflammatory bowel disease in rats
10.1007/978-1-4899-0117-0_37 · 1998 · External reference
Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats
10.1007/bf02975370 · 1998 · External reference
10.1007/s00726-007-0562-8
10.1007/s00726-007-0562-8 · External reference
10.1016/j.cell.2015.10.048
10.1016/j.cell.2015.10.048 · External reference
10.1016/j.cell.2020.12.011
10.1016/j.cell.2020.12.011 · External reference
A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota/taurine/tight junction axis
10.1172/jci.insight.132055 · 2020 · External reference
10.3748/wjg.v27.i24.3609
10.3748/wjg.v27.i24.3609 · External reference
10.1136/gutjnl-2012-302578
10.1136/gutjnl-2012-302578 · External reference
10.1016/j.chom.2020.01.021
10.1016/j.chom.2020.01.021 · External reference
Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids
10.1186/s40168-019-0740-4 · 2019 · External reference
Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids
10.1128/iai.00045-20 · 2020 · External reference
Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism
10.1016/j.phrs.2021.105767 · 2021 · External reference
10.1093/ibd/izaa007
10.1093/ibd/izaa007 · External reference
Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer
2021 · External reference
Metagenomic analysis of bile salt biotransformation in the human gut microbiome
10.1186/s12864-019-5899-3 · 2019 · External reference
Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease
10.1080/19490976.2020.1865708 · 2021 · External reference
10.1136/gut.2010.212159
10.1136/gut.2010.212159 · External reference
10.1152/ajpgi.00256.2016
10.1152/ajpgi.00256.2016 · External reference
10.14814/phy2.14456
10.14814/phy2.14456 · External reference
The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing
10.1152/ajpgi.00435.2016 · 2018 · External reference
10.3748/wjg.v18.i9.923
10.3748/wjg.v18.i9.923 · External reference
10.1007/s10620-020-06208-3
10.1007/s10620-020-06208-3 · External reference
Mass spectrometry-based metabolomics in microbiome investigations
2021 · External reference
10.1038/s41592-019-0616-3
10.1038/s41592-019-0616-3 · External reference
10.1038/s41586-021-03707-9
10.1038/s41586-021-03707-9 · External reference
10.1016/j.csbj.2021.11.028 · Admitted local publication
Performance determinants of unsupervised clustering methods for microbiome data
10.1186/s40168-021-01199-3 · 2022 · External reference
Advances in decomposing complex metabolite mixtures using substructure- and network-based computational metabolomics approaches
10.1039/d1np00023c · 2021 · External reference
10.1186/s40168-021-01213-8
10.1186/s40168-021-01213-8 · External reference
10.1016/j.copbio.2020.10.005
10.1016/j.copbio.2020.10.005 · External reference
PaintOmics 3: a web resource for the pathway analysis and visualization of multi-omics data
10.1093/nar/gky466 · 2018 · External reference
10.1136/gutjnl-2020-321106
10.1136/gutjnl-2020-321106 · External reference
10.1053/j.gastro.2004.03.024
10.1053/j.gastro.2004.03.024 · External reference
Manipulating the gut microbiota to maintain health and treat disease
2015 · External reference
Role of antibiotics for treatment of inflammatory bowel disease
10.3748/wjg.v22.i3.1078 · 2016 · External reference
Diagnosis and management of inflammatory bowel disease in children
10.1136/bmj.j2083 · 2017 · External reference
Use of antibiotics in patients with Crohn's disease: a systematic review and meta-analysis
10.1111/1751-2980.12216 · 2015 · External reference
The efficacy of tobramycin in the treatment of ulcerative colitis
10.1111/j.1365-2036.1990.tb00456.x · 1990 · External reference
Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease
10.3390/ijms22041623 · 2021 · External reference
10.1136/gutjnl-2016-312297
10.1136/gutjnl-2016-312297 · External reference
Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study
10.3390/ijms17050649 · 2016 · External reference
10.1007/s00253-019-10165-x
10.1007/s00253-019-10165-x · External reference
Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome
10.3390/nu13082814 · 2021 · External reference
Repeated fecal microbial transplantations and antibiotic pre-treatment are linked to improved clinical response and remission in inflammatory bowel disease: a systematic review and pooled proportion meta-analysis
10.3390/jcm10050959 · 2021 · External reference
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
10.1016/j.ebiom.2021.103293 · 2021 · External reference
Butyrate does not protect against inflammation-induced loss of epithelial barrier function and cytokine production in primary cell monolayers from patients with ulcerative colitis
10.1093/ecco-jcc/jjz064 · 2019 · External reference
10.1016/j.cgh.2020.05.026
10.1016/j.cgh.2020.05.026 · External reference
10.1186/s40168-021-01115-9
10.1186/s40168-021-01115-9 · External reference
10.1021/acsnano.9b09125
10.1021/acsnano.9b09125 · External reference
Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial
2021 · External reference
10.1038/s41575-019-0173-3
10.1038/s41575-019-0173-3 · External reference
Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis, Microb
2020 · External reference
Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial Applications
10.3389/fmicb.2017.01889 · 2017 · External reference
10.1097/01.mib.0000440815.76627.64
10.1097/01.mib.0000440815.76627.64 · External reference
10.1073/pnas.0804812105
10.1073/pnas.0804812105 · External reference
Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3
10.1080/19490976.2020.1826748 · 2020 · External reference
10.1038/s41591-019-0495-2
10.1038/s41591-019-0495-2 · External reference
Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation
10.1128/spectrum.00730-21 · 2021 · External reference
Akkermansia muciniphilaA purified membrane protein from or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 T cells in mice
2020 · External reference
10.3389/fcimb.2019.00239
10.3389/fcimb.2019.00239 · External reference
10.1007/s00253-021-11453-1
10.1007/s00253-021-11453-1 · External reference
10.1016/j.addr.2021.113863
10.1016/j.addr.2021.113863 · External reference
for the delivery of matrix-tethered therapeutic domains to the gut
1917 · External reference
10.1038/s41423-021-00760-2
10.1038/s41423-021-00760-2 · External reference
An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis
10.1002/btm2.10219 · 2021 · External reference
10.1038/nrgastro.2017.75
10.1038/nrgastro.2017.75 · External reference
Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis
10.1007/s00394-021-02503-5 · 2021 · External reference
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial
10.1038/ctg.2012.24 · 2013 · External reference
Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study
10.1046/j.1365-2036.1998.00432.x · 1998 · External reference
Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study
10.1097/00054725-200303000-00005 · 2003 · External reference
Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels
10.1080/19490976.2018.1526583 · 2019 · External reference
Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial
10.1136/gutjnl-2011-300413 · 2012 · External reference
Dietary Fiber Pectin Ameliorates Experimental Colitis in a Neutral Sugar Side Chain-Dependent Manner
10.3389/fimmu.2019.02979 · 2019 · External reference
Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin-10 knockout mice
10.1021/jf103262s · 2010 · External reference
Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora
10.1186/s12866-016-0869-2 · 2016 · External reference
10.1053/j.gastro.2017.11.030
10.1053/j.gastro.2017.11.030 · External reference
Dietary cranberry suppressed colonic inflammation and alleviated gut microbiota dysbiosis in dextran sodium sulfate-treated mice
10.1039/c9fo01537j · 2019 · External reference
Prebiotic effects of goji berry in protection against inflammatory bowel disease
2022 · External reference
10.1007/s10620-020-06090-z
10.1007/s10620-020-06090-z · External reference
10.1111/apt.15818
10.1111/apt.15818 · External reference
Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised
2017 · External reference
Effects of Low FODMAP Diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial
10.1053/j.gastro.2019.09.024 · 2020 · External reference
A Randomized trial comparing the specific carbohydrate diet to a mediterranean diet in adults with Crohn's disease
10.1053/j.gastro.2021.05.047 · 2021 · External reference
10.1038/s41575-020-0344-2
10.1038/s41575-020-0344-2 · External reference
Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis
10.1080/19490976.2020.1854640 · 2020 · External reference
10.1001/jama.2017.17077
10.1001/jama.2017.17077 · External reference
Effect of faecal microbiota transplantation for treatment of clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies
10.1093/ecco-jcc/jjy031 · 2018 · External reference
Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy
10.1111/apt.13969 · 2017 · External reference
Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent clostridium difficile infection
10.1053/j.gastro.2018.12.019 · 2019 · External reference
10.1016/s0140-6736(19)31266-8
10.1016/s0140-6736(19)31266-8 · External reference
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
10.1053/j.gastro.2015.03.045 · 2015 · External reference
10.1053/j.gastro.2015.04.001
10.1053/j.gastro.2015.04.001 · External reference
Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial
10.1001/jama.2018.20046 · 2019 · External reference
10.1053/j.gastro.2018.12.001
10.1053/j.gastro.2018.12.001 · External reference
10.1038/ajg.2013.257
10.1038/ajg.2013.257 · External reference
Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection
10.1016/j.crohns.2013.10.002 · 2014 · External reference
10.1111/jgh.12727
10.1111/jgh.12727 · External reference
Alternative and complementary approaches for the treatment of inflammatory bowel disease: evidence from cochrane reviews
10.1093/ibd/izz223 · 2020 · External reference
10.2217/nnm-2021-0167
10.2217/nnm-2021-0167 · External reference
10.1016/j.chom.2018.10.001
10.1016/j.chom.2018.10.001 · External reference
10.1016/j.cell.2013.11.024
10.1016/j.cell.2013.11.024 · External reference
10.1073/pnas.1215927110
10.1073/pnas.1215927110 · External reference
Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases
10.3390/ijms22041942 · 2021 · External reference
10.1038/s41563-019-0462-9
10.1038/s41563-019-0462-9 · External reference
Integration of spatial and single-cell transcriptomic data elucidates mouse organogenesis
2021 · External reference
10.1038/s41586-019-1065-y
10.1038/s41586-019-1065-y · External reference
10.1111/1751-2980.12795
10.1111/1751-2980.12795 · External reference
10.1136/gutjnl-2015-309940
10.1136/gutjnl-2015-309940 · External reference
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients, Cell Mol
2016 · External reference
